Published in:
Volume 4 / Year 2015 / Issue 1

The EU regulatory approach to generics and biosimilars is essentially similar

Author(s): , , ,
Page: 9-10

Abstract: Notwithstanding the scientific and regulatory differences between generic and biosimilar medicines, the European Medicines Agency/Committee for Medicinal Products for Human Use has consistently applied a ‘same active substance’ approach… Read More »

Go Back Print